1Krag DN, Weaver DL, Alex JC, et al. Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol, 1993, 2: 335-339.
2Liberman L, Cody HS Ⅲ, Hill AD, et al. Sentinel lymph node biopsy after percutaneous diagnosis of nonpalpable breast cancer.Radiology, 1999, 211 : 835-844.
3Doting MH, Jansen L, Nieweg OE, et al. Lymphatic mapping with intralesional tracer administration in breast carcinoma patients.Cancer, 2000, 88: 2546-2552.
4Cady B. Sentinel lymph node biopsy as an alternative to routine axillary lymph node dissection in breast cancer patients. J SurgOncol, 2001,77 : 149-152.
5Shimazu K, Tamaki Y, Taguchi T, et al. Comparison between periareolar and peritumoral injection of radiotracer for sentinel lymph node biopsy in patients with breast cancer. Surgery, 2002, 131 :277 -286.
6Borgstein PJ, Meijer S, Pijpers R J, et al. Functional lymphatic anatomy for sentinel node biopsy in breast cancer: echoes from the past and periareolar blue method. Ann Surg, 2000, 232: 81-89.
7Krag D, Weaver D, Ashikaga T, et al. The sentinel node in breast cancer-a multicenter validation study. N Engl J Med, 1998, 339:941-946.
8Roumen RM, Valkenburg JG, Geuskens LM. Lymphoscintigraphy and feasibility of sentinel node biopsy in 83 patients with primary breast cancer. Eur J Surg Oncol, 1997, 23 : 495-502.
9Cox CE, Pendas S, Cox JM, et al. Guidelines for the sentinel node biopsy and lymphatic of patients with breast cancer. Ann Surg,1998, 227 : 645-651.
10Snider H, Dowlatshahi K, Fan M, et al. Sentinel node biopsy in the staging of breast cancer. Am J Surg, 1998, 176:305-310.
7Taddei S, Nami R, Bruno RM, et al. Hypertension, leftven- tricularhypertrophy and chronic kidney disease[J]. Heart Fail Rev,2011,16(6) :615-620.
8Guideline Working Group. Japanese Society for Dialysis Therapy. Clinical practiceguideline for the management of secondary hyperparathyr, Jidism in chronic dialys!spatients[J]. Ther Apher Dial, 2008, 12(6) : 514-525.
9Kidney Disease : Improving Global Outcomes ( KDIGO ) CKD-MBD Work Grou?. KDIGO clinical practice guide- lines for the diagnosis, evaluation, prevention, and treat- ment of Chronic Kidney Disease-Mineral and Bone Dis-order (CKD-MBD) [J]. Kidney Int Suppl, 2009,8 (113) : 1- 130.
10Goldsmith D J A,Covic A,Fouque D,et al. Endorsement of the Kidney Disease Improving Global Outcomes (KDI- GO)Chronic Kidney Disease-Mineral and BoneDisorder (CKD-MBD)Guidelines:A European Renal Best Practice (ERBP)commentary statement[J]. Nephrol Dial Transpl, 2010,25(12) :3823-3831.
